Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Interpack 2014: Sterile and Ready to Use Packaging by SCHOTT

Published: Thursday, May 08, 2014
Last Updated: Thursday, May 08, 2014
Bookmark and Share
SCHOTT’s sterile, ready to use vials adaptiQ™ will be on display at Interpack.

At Interpack 2014, SCHOTT will be demonstrating how close cooperation with leading machine manufacturers such as Bausch+Stroebel, Bosch Packaging Technology and OPTIMA can culminate in flexible, new packaging solutions.

SCHOTT discusses its innovative product ideas with these machine manufacturers already during the development phase. The mutual customers - pharmaceutical companies - therefore benefit from an integrated, highly efficient filling process in which the primary packaging and filling lines are perfectly tuned to each other.

With the sterile, ready to use vials adaptiQ™ that will be on display at Interpack, the partners will be catering to one of the most important trends in the pharmaceutical industry: flexible manufacturing strategies that allow for different substance-packaging configurations to be filled efficiently.

adaptiQ will be on exhibit at SCHOTT’s booth (hall 7a, B01) and its partners’ booths at Interpack. The system consists of a so-called nest and tub configuration in which up to 100 ready to use pharmaceutical vials are securely fixed inside the nest in sterile packaging for delivery to the pharmaceutical companies. They can then fill the vials immediately on their filling lines without having to wash or sterilize them first. In fact, they can even fill them on the lines that are normally used to fill nested syringes.

In order to keep the set-up times for changing packaging as short as possible, adaptiQ is orientated towards the proven tub format used in syringe manufacturing. This means pharmaceutical companies can use the same production line for various types of containers and formats after making only minor adjustments.

Although it is embedded in a standard tub, the SCHOTT adaptiQ solution features a nest design that offers advantages over all of the other ready-to-use solutions commonly available today: The vials are held by the neck in the adaptiQ nest and can be lifted or pulled out together inside the nest, to weigh or close them, for example.

Furthermore, the bottom is freely accessible and this ensures just the right temperature transition during lyophilization in particular. For the first time ever, all of the process steps can be performed without having to remove the vials from the nest.

SCHOTT will offer adaptiQ in the common 2R and 4R ISO formats to start with at the end of 2014. The company is already preparing to expand its portfolio rather quickly.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

SCHOTT Launches New Center of Excellence for RTU Pharma Packaging
Initiative will more closely tie together SCHOTT’s experts and pharma partners as production of adaptiQ® ready-to-use vials commences.
Saturday, October 24, 2015
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Flu Vaccine May Reduce Risk of Death For Type 2 Diabetes Patients
Researchers at Imperial College London have suggested that the vaccine may have substantial benefits for patients with long-term conditions.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
Porphyrins as Catalysts in Scalable Organic Reactions
This review covers the most relevant scalable porphyrin-catalysed procedures, showing how these compounds represent broad applications in chemistry.
CDC Updates Zika Recommendations
CDC has issued updated Zika recommendations and guidance for healthcare providers with a focus on sexual transmission.
Exploiting Malaria’s Achilles’ Heel
Researchers have uncovered an Achilles' heel in malaria's anti-drug treatment arsenal that could lead to a disease cure.
Genome of 6000-Year-Old Barley Sequenced
Researchers have successfully sequenced the genome of Chalcolithic barley grains for the first time.
3D Models May Yield Ovarian Cancer Insights
Researchers are developing new tools to decipher ovarian cancer developments through a 3D printing technology.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Plant Compounds Fight Together Against Colon Cancer
Research shows treating colon cancer cells with curcumin, then silymarin is more effective than treatment with each individually.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!